FDA Investigator

Nancy E Byerly

Latest inspection on record: Duvall, United States, June 2017 · records back to 2008

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 130 inspections across 104 sites are on record.
  • 463 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2017-06-15.

At a glance

Inspections

130

Sites

104

Observations

463

Career since

Jan 2008

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Esteem Products LTD15 Jun 2017Human DrugsView 483 →
Hemcare of Oregon, Inc.26 Apr 2017Human DrugsView 483 →
Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center8 Mar 2017Human DrugsOn file
Bio Energetics, Inc13 Dec 2016Human Drugs
McCoy-Simpson, LLC20 Oct 2016Human Drugs

Sites inspected

Esteem Products LTDDuvall, United States1 insp.
Hemcare of Oregon, Inc.Wilsonville, United States1 insp.
Bio Energetics, IncSandy, United States1 insp.
McCoy-Simpson, LLCSeattle, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Anita Narula2 shared
Lawrence Y Lee2 shared
Tracy K Li1 shared

Full investigator report

Get the verbatim findings behind Nancy E Byerly's 463 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site